{"id": "M3rqwfgAAAAJ", "citedby": 3250, "citedby5y": 1812, "hindex": 27, "hindex5y": 23, "i10index": 46, "i10index5y": 41, "coauthors": [], "name": "Atsushi Sakuraba", "affiliation": "The University of Chicago Medicine", "interests": [], "cites_per_year": {"2004": 13, "2005": 48, "2006": 49, "2007": 72, "2008": 89, "2009": 129, "2010": 171, "2011": 214, "2012": 184, "2013": 216, "2014": 212, "2015": 240, "2016": 261, "2017": 320, "2018": 357, "2019": 432, "2020": 185}, "publications": [{"bib": {"title": "Unique CD14+ intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-\u03b3 axis", "year": "2008"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:u5HHmVD_uO8C", "citedby": "571"}, {"bib": {"title": "Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease", "year": "2008"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:u-x6o8ySG0sC", "citedby": "281"}, {"bib": {"title": "Th1/Th17 immune response is induced by mesenteric lymph node dendritic cells in Crohn's disease", "year": "2009"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:UeHWp8X0CEIC", "citedby": "214"}, {"bib": {"title": "Cytomegalovirus is frequently reactivated and disappears without antiviral agents in ulcerative colitis patients", "year": "2007"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:d1gkVwhDpl0C", "citedby": "204"}, {"bib": {"title": "T-bet upregulation and subsequent interleukin 12 stimulation are essential for induction of Th1 mediated immunopathology in Crohn\u2019s disease", "year": "2004"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:qjMakFHDy7sC", "citedby": "155"}, {"bib": {"title": "Animal models of inflammatory bowel disease", "year": "2002"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:9yKSN-GCB0IC", "citedby": "137"}, {"bib": {"title": "Osteopontin/Eta-1 upregulated in Crohn\u2019s disease regulates the Th1 immune response", "year": "2005"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:IjCSPb-OGe4C", "citedby": "130"}, {"bib": {"title": "Granulocytapheresis is useful as an alternative therapy in patients with steroid-refractory or-dependent ulcerative colitis", "year": "2004"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:2osOgNQ5qMEC", "citedby": "114"}, {"bib": {"title": "An open-label prospective randomized multicenter study shows very rapid remission of ulcerative colitis by intensive granulocyte and monocyte adsorptive apheresis as compared \u2026", "year": "2009"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:Tyk-4Ss8FVUC", "citedby": "112"}, {"bib": {"title": "Efficacy of infliximab for induction and maintenance of remission in intestinal Beh\u00e7et's disease", "year": "2008"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:zYLM7Y9cAGgC", "citedby": "100"}, {"bib": {"title": "Systematic review with meta\u2010analysis: the efficacy and safety of CT\u2010P13, a biosimilar of anti\u2010tumour necrosis factor\u2010\u03b1 agent (infliximab), in inflammatory bowel diseases", "year": "2017"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:4fKUyHm3Qg0C", "citedby": "79"}, {"bib": {"title": "Retrieval of serum infliximab level by shortening the maintenance infusion interval is correlated with clinical efficacy in Crohn's disease", "year": "2012"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:ufrVoPGSRksC", "citedby": "62"}, {"bib": {"title": "C-reactive protein is an indicator of serum infliximab level in predicting loss of response in patients with Crohn\u2019s disease", "year": "2014"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:8k81kl-MbHgC", "citedby": "54"}, {"bib": {"title": "Efficacy and safety of medical therapy for low bone mineral density in patients with inflammatory bowel disease: a meta-analysis and systematic review", "year": "2014"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:Se3iqnhoufwC", "citedby": "53"}, {"bib": {"title": "Hyperexpression of inducible costimulator and its contribution on lamina propria T cells in inflammatory bowel disease", "year": "2004"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:Y0pCki6q_DkC", "citedby": "52"}, {"bib": {"title": "Risk of postoperative complications among inflammatory bowel disease patients treated preoperatively with vedolizumab", "year": "2017"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:BrmTIyaxlBUC", "citedby": "49"}, {"bib": {"title": "Serum 25-hydroxyvitamin D concentration is inversely associated with mucosal inflammation in patients with ulcerative colitis", "year": "2016"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:KxtntwgDAa4C", "citedby": "48"}, {"bib": {"title": "Outcome of pregnancy and neonatal complications with anti-tumor necrosis factor-\u03b1 use in females with immune mediated diseases; a systematic review and meta-analysis", "year": "2017"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:uWQEDVKXjbEC", "citedby": "45"}, {"bib": {"title": "A pilot open-labeled prospective randomized study between weekly and intensive treatment of granulocyte and monocyte adsorption apheresis for active ulcerative colitis", "year": "2008"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:W7OEmFMy1HYC", "citedby": "45"}, {"bib": {"title": "Efficacy and safety of tacrolimus therapy for active ulcerative colitis; a systematic review and meta-analysis", "year": "2016"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:dfsIfKJdRG4C", "citedby": "39"}, {"bib": {"title": "Natalizumab in Crohn\u2019s disease: results from a US tertiary inflammatory bowel disease center", "year": "2013"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:_FxGoFyzp5QC", "citedby": "38"}, {"bib": {"title": "Risk of gastrointestinal cancers in patients with cystic fibrosis: a systematic review and meta-analysis", "year": "2018"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:Y5dfb0dijaUC", "citedby": "37"}, {"bib": {"title": "Prevalence of serum celiac antibody in patients with IBD in Japan", "year": "2014"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:0EnyYjriUFMC", "citedby": "36"}, {"bib": {"title": "Efficacy, safety and pharmacokinetics of biosimilars of anti-tumor necrosis factor-\u03b1 agents in rheumatic diseases; A systematic review and meta-analysis", "year": "2017"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:08ZZubdj9fEC", "citedby": "30"}, {"bib": {"title": "Comparison of efficacy, pharmacokinetics, and immunogenicity between infliximab mono\u2010versus combination therapy in ulcerative colitis", "year": "2014"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:aqlVkmm33-oC", "citedby": "30"}, {"bib": {"title": "Endoscopic and pathologic changes of the upper gastrointestinal tract in Crohn\u2019s disease", "year": "2014"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:kNdYIx-mwKoC", "citedby": "30"}, {"bib": {"title": "Mucosal healing is associated with improved long-term outcome of maintenance therapy with natalizumab in Crohn's disease", "year": "2013"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:MXK_kJrjxJIC", "citedby": "27"}, {"bib": {"title": "The use of infliximab in the prevention of postsurgical recurrence in polysurgery Crohn's disease patients: a pilot open-labeled prospective study", "year": "2012"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:LkGwnXOMwfcC", "citedby": "25"}, {"bib": {"title": "Lower doses of 6-mercaptopurine/azathioprine bring enough clinical efficacy and therapeutic concentration of erythrocyte 6-mercaptopurine metabolite in Japanese IBD patients", "year": "2008"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:WF5omc3nYNoC", "citedby": "25"}, {"bib": {"title": "Is there a role for apheresis in gastrointestinal disorders?", "year": "2005"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:YsMSGLbcyi4C", "citedby": "24"}, {"bib": {"title": "Comparison of real-world outcomes of adalimumab and infliximab for patients with ulcerative colitis in the United States", "year": "2016"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:xtRiw3GOFMkC", "citedby": "22"}, {"bib": {"title": "Granulocyte and monocyte adsorption apheresis therapy modulates monocyte\u2010derived dendritic cell function in patients with ulcerative colitis", "year": "2009"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:roLk4NBRz8UC", "citedby": "20"}, {"bib": {"title": "Update on the management of ulcerative colitis", "year": "2011"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:eQOLeE2rZwMC", "citedby": "19"}, {"bib": {"title": "Real-world experience with tofacitinib in IBD at a tertiary center", "year": "2019"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:evX43VCCuoAC", "citedby": "18"}, {"bib": {"title": "Risk of colorectal cancer in chronic liver diseases: a systematic review and meta-analysis", "year": "2017"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:1sJd4Hv_s6UC", "citedby": "18"}, {"bib": {"title": "Rapid onset of inflammatory bowel disease after receiving secukinumab infusion", "year": "2018"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:hkOj_22Ku90C", "citedby": "16"}, {"bib": {"title": "Risk of Cancer Recurrence Among Individuals Exposed to Antitumor Necrosis Factor Therapy", "year": "2019"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:q3oQSFYPqjQC", "citedby": "15"}, {"bib": {"title": "Meta\u2010analysis of the risk of immune\u2010related adverse events with anticytotoxic T\u2010lymphocyte\u2010associated antigen 4 and antiprogrammed death 1 therapies", "year": "2018"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:K3LRdlH-MEoC", "citedby": "15"}, {"bib": {"title": "Factors associated with readmission to the hospital within 30 days in patients with inflammatory bowel disease", "year": "2017"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:kRWSkSYxWN8C", "citedby": "15"}, {"bib": {"title": "The use of vedolizumab in preventing postoperative recurrence of Crohn\u2019s disease", "year": "2018"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:HE397vMXCloC", "citedby": "14"}, {"bib": {"title": "Age of diagnosis is associated with disease presentation and therapeutic complications in patients with Crohn's disease", "year": "2016"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:abG-DnoFyZgC", "citedby": "13"}, {"bib": {"title": "Approach to optimize anti-TNF-\u03b1 therapy in patients with IBD", "year": "2016"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:_xSYboBqXhAC", "citedby": "12"}, {"bib": {"title": "Tu1350 vedolizumab in the treatment of IBD: the University of Chicago experience", "year": "2015"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:f2IySw72cVMC", "citedby": "12"}, {"bib": {"title": "Utility of video capsule endoscopy for longitudinal monitoring of Crohn\u2019s disease activity in the small bowel: a prospective study", "year": "2018"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:VOx2b1Wkg3QC", "citedby": "11"}, {"bib": {"title": "Prevalence of antibodies against JC virus in patients with refractory Crohn\u2019s disease and effects of natalizumab therapy", "year": "2015"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:RGFaLdJalmkC", "citedby": "11"}, {"bib": {"title": "The benefit of combination therapy depends on disease phenotype and duration in Crohn's disease", "year": "2017"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:D_sINldO8mEC", "citedby": "10"}, {"bib": {"title": "Risk of Fractures in Inflammatory Bowel Diseases", "year": "2019"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:ye4kPcJQO24C", "citedby": "9"}, {"bib": {"title": "Ulcerative colitis: prevention of relapse", "year": "2013"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:bEWYMUwI8FkC", "citedby": "9"}, {"bib": {"title": "Management of inflammatory bowel disease: past, present and future", "year": "2012"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:hqOjcs7Dif8C", "citedby": "9"}, {"bib": {"title": "Intensive therapy of granulocyte and monocyte adsorption apheresis induces rapid remission in patients with ulcerative colitis", "year": "2003"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:UebtZRa9Y70C", "citedby": "9"}, {"bib": {"title": "Pharmacologic therapies for severe steroid refractory hospitalized ulcerative colitis: a network meta\u2010analysis", "year": "2017"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:OU6Ihb5iCvQC", "citedby": "8"}, {"bib": {"title": "Combination therapy with infliximab and thiopurine compared to infliximab monotherapy in maintaining remission of postoperative Crohn's disease", "year": "2015"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:M3NEmzRMIkIC", "citedby": "8"}, {"bib": {"title": "Intermittent granulocyte and monocyte apheresis versus mercaptopurine for maintaining remission of ulcerative colitis: a pilot study", "year": "2012"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:_kc_bZDykSQC", "citedby": "8"}, {"bib": {"title": "Preoperative Right-Sided Cardiac Congestion Is Associated with Gastrointestinal Bleeding in Patients with Continuous-Flow Left Ventricular Assist Devices", "year": "2018"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:olpn-zPbct0C", "citedby": "7"}, {"bib": {"title": "Ciclosporin therapy after infliximab failure in hospitalized patients with acute severe colitis is effective and safe", "year": "2019"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:-_dYPAW6P2MC", "citedby": "6"}, {"bib": {"title": "EUS-guided fiducial placement for GI malignancies: a systematic review and meta-analysis", "year": "2019"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:VL0QpB8kHFEC", "citedby": "6"}, {"bib": {"title": "A Multicenter, Randomized, Controlled Trial between Weekly and Semiweekly Treatment with Granulocyte and Monocyte Adsorption Apheresis for Active Ulcerative Colitis: 872", "year": "2005"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:5nxA0vEk-isC", "citedby": "6"}, {"bib": {"title": "Ustekinumab Is effective for the treatment of chronic antibiotic-refractory pouchitis", "year": "2019"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:g3aElNc5_aQC", "citedby": "5"}, {"bib": {"title": "Systematic review with meta\u2010analysis: risk of new onset IBD with the use of anti\u2010interleukin\u201017 agents", "year": "2019"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:kuK5TVdYjLIC", "citedby": "5"}, {"bib": {"title": "Two complex cases of Hermansky-Pudlak syndrome highlight a potential biologic explanation for an associated Crohn\u2019s disease phenotype", "year": "2017"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:l7t_Zn2s7bgC", "citedby": "5"}, {"bib": {"title": "Sa2044 Decrease in Serum Infliximab Level Precedes Loss of Clinical Response and Can Be Easily Detected by the Elevation of C-Reactive Protein in Crohn's Disease", "year": "2012"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:KlAtU1dfN6UC", "citedby": "5"}, {"bib": {"title": "Risk Factors for Clostridium difficile Isolation in Inflammatory Bowel Disease: A Prospective Study", "year": "2018"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:t6usbXjVLHcC", "citedby": "4"}, {"bib": {"title": "Endoscopic and Histologic Response and Remission in Inflammatory Bowel Disease Patients Initiating Vedolizumab: 1843", "year": "2015"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:_Ybze24A_UAC", "citedby": "4"}, {"bib": {"title": "Post-marketing experience of vedolizumab for IBD: The University of Chicago experience", "year": "2015"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:J_g5lzvAfSwC", "citedby": "4"}, {"bib": {"title": "INTERMITTENT THERAPY WITH GRANULOCYTE AND MONOCYTE APHAERESIS MAINTAINS REMISSION IN ULCERATIVE COLITIS: 797", "year": "2004"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:3fE2CSJIrl8C", "citedby": "4"}, {"bib": {"title": "Sa1258 Comparison of Real-World Outcomes of Adalimumab (ADA) and Infliximab (IFX) for Patients With Ulcerative Colitis (UC) in the United States", "year": "2015"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:YFjsv_pBGBYC", "citedby": "3"}, {"bib": {"title": "Su1217 A Comparison of Efficacy, Pharmacokinetics and Immunogenicity in Patients With Ulcerative Colitis Receiving Infliximab Monotherapy Versus Combination Therapy", "year": "2013"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:4TOpqqG69KYC", "citedby": "3"}, {"bib": {"title": "An open-labeled trial of granulocyte and monocyte adsorption apheresis for pouchitis", "year": "2006"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:Zph67rFs4hoC", "citedby": "3"}, {"bib": {"title": "Efficacy and safety of induction therapy with calcineurin inhibitors followed by vedolizumab maintenance in 71 patients with severe steroid\u2010refractory ulcerative colitis", "year": "2020"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:HtEfBTGE9r8C", "citedby": "2"}, {"bib": {"title": "Differential risk of disease progression between isolated anastomotic ulcers and mild ileal recurrence after ileocolonic resection in patients with Crohn\u2019s disease", "year": "2019"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:35r97b3x0nAC", "citedby": "2"}, {"bib": {"title": "Follow-Up of Patients With Ulcerative Colitis and Histological Normalization.", "year": "2019"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:p__nRnzSRKYC", "citedby": "2"}, {"bib": {"title": "A comparison of the risk of postoperative recurrence between African\u2010American and Caucasian patients with Crohn's disease", "year": "2018"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:dQ2og3OwTAUC", "citedby": "2"}, {"bib": {"title": "Gastrointestinal cancers in patients with cystic fibrosis\u2013Authors' reply", "year": "2018"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:PR6Y55bgFSsC", "citedby": "2"}, {"bib": {"title": "Efficacy of Pharmacologic Therapy for Eosinophilic Esophagitis", "year": "2018"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:mvPsJ3kp5DgC", "citedby": "2"}, {"bib": {"title": "Correlation Between Clinical, Endoscopic, and Histologic Disease Activity in Ulcerative Colitis: 1712", "year": "2012"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:ULOm3_A8WrAC", "citedby": "2"}, {"bib": {"title": "The formation of leukocyte-platelets complex in patients with ulcerative colitis: a novel marker for the disease activity and response to granulocytapheresis", "year": "2004"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:YOwf2qJgpHMC", "citedby": "2"}, {"bib": {"title": "Non-adherence to Medications in Pregnant Ulcerative Colitis Patients Contributes to Disease Flares and Adverse Pregnancy Outcomes", "year": "2020"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:4vMrXwiscB8C", "citedby": "1"}, {"bib": {"title": "Follow-Up of Patients With Ulcerative Colitis and Histological Normalization", "year": "2020"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:sNmaIFBj_lkC", "citedby": "1"}, {"bib": {"title": "Effectiveness of ustekinumab dose escalation in patients with crohn\u2019s disease", "year": "2020"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:OTTXONDVkokC", "citedby": "1"}, {"bib": {"title": "DOP045 Combination therapy with anti-TNF and immunosuppressive therapies is the most effective medication to prevent and treat endoscopic postoperative recurrence in patients \u2026", "year": "2018"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:bnK-pcrLprsC", "citedby": "1"}, {"bib": {"title": "Efficacy of Various Endoscopic Modalities in Detecting Neoplasia in Ulcerative Colitis: A Systematic Review and Network Meta-Analysis", "year": "2017"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:eJXPG6dFmWUC", "citedby": "1"}, {"bib": {"title": "P454 Can calcineurin inhibitors induce a durable remission that is maintained with vedolizumab in IBD?", "year": "2017"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:tS2w5q8j5-wC", "citedby": "1"}, {"bib": {"title": "Risk of colorectal cancer in chronic liver diseases: a systematic review and meta-analysis.", "year": "2016"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:j8SEvjWlNXcC", "citedby": "1"}, {"bib": {"title": "Novel Topics in Inflammatory Bowel Disease", "year": "2016"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:b0M2c_1WBrUC", "citedby": "1"}, {"bib": {"title": "Tu1349 The Efficacy and Safety of Calcineurin Inhibitors in Inducing and Maintaining Clinical Remission in IBD Patients Commencing Vedolizumab", "year": "2015"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:bFI3QPDXJZMC", "citedby": "1"}, {"bib": {"title": "Tu1351 Crohn's Disease Patients Currently or Previously on Natalizumab Can Be Safely and Effectively Switched to Vedolizumab", "year": "2015"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:GnPB-g6toBAC", "citedby": "1"}, {"bib": {"title": "Tu1118 Comparison of Efficacy of Pharmacologic Therapy of Eosinophilic Esophagitis (EoE): A Systematic Review and Network Meta-Analysis", "year": "2015"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:BqipwSGYUEgC", "citedby": "1"}, {"bib": {"title": "Sa1141 Assessment of Injection Site Reactions Related to Anti-TNF Therapies in Inflammatory Bowel Disease", "year": "2015"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:blknAaTinKkC", "citedby": "1"}, {"bib": {"title": "Calcineurin inhibitors are safe and effective for induction of remission in patients commencing vedolizumab for IBD", "year": "2015"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:NaGl4SEjCO4C", "citedby": "1"}, {"bib": {"title": "Parastomal Variceal Bleeding Attributed to Obstructive Pathology Successfully Treated by Percutaneous Variceal Embolization", "year": "2014"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:maZDTaKrznsC", "citedby": "1"}, {"bib": {"title": "P-074 Age of Diagnosis Is Associated with the Severity of Adverse Effects to Therapy in Crohn\u2019s Disease Patients", "year": "2013"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:4DMP91E08xMC", "citedby": "1"}, {"bib": {"title": "Age of Diagnosis Is Associated with Disease Phenotype and Behavior in Crohn's Disease Patients: 1782", "year": "2013"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:hFOr9nPyWt4C", "citedby": "1"}, {"bib": {"title": "Low dose of 6-mercaptopurine (30mg/day) or azathioprine (50mg/day) is effective for the maintenance of remission in IBD", "year": "2003"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:M3ejUd6NZC8C", "citedby": "1"}, {"bib": {"title": "Efficacy of various endoscopic modalities in detecting dysplasia in ulcerative colitis: A systematic review and network meta-analysis", "year": "2020"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:3htObqc8RwsC", "citedby": "0"}, {"bib": {"title": "Risk factors and treatment outcomes of peristomal pyoderma gangrenosum in patients with inflammatory bowel disease", "year": "2020"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:OcBU2YAGkTUC", "citedby": "0"}, {"bib": {"title": "Efficacy and Safety of Monoclonal Antibodies Against Clostridioides difficile Toxins for Prevention of Recurrent Clostridioides difficile Infection: A Systematic Review and \u2026", "year": "2020"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:mlAyqtXpCwEC", "citedby": "0"}, {"bib": {"title": "Per oral endoscopic myotomy as salvage therapy in patients with achalasia refractory to endoscopic or surgical therapy is technically feasible and safe: Systematic review and \u2026", "year": "2020"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:mNrWkgRL2YcC", "citedby": "0"}, {"bib": {"title": "POEM as salvage therapy in patients with achalasia refractory to endoscopic or surgical therapy is technically feasible and safe: A systematic review and meta-analysis.", "year": "2020"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:IRz6iEL74y4C", "citedby": "0"}, {"bib": {"title": "24 ENDOSCOPIC AND CLINICAL CHARACTERISTICS OF POUCHITIS INVOLVING THE RECTAL CUFF IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED BY PROCTOCOLECTOMY WITH ILEAL POUCH-ANAL \u2026", "year": "2020"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:_5tno0g5mFcC", "citedby": "0"}, {"bib": {"title": "Efficacy and safety of induction therapy with calcineurin inhibitors followed by maintenance therapy with vedolizumab in severe ulcerative colitis: a large patient cohort with \u2026", "year": "2020"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:DJbcl8HfkQkC", "citedby": "0"}, {"bib": {"title": "Acute severe ulcerative colitis in pregnancy: A retrospective cohort study", "year": "2020"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:cWzG1nlazyYC", "citedby": "0"}, {"bib": {"title": "P002 Endoscopic Characteristics and Prognosis of Pouchitis Involving the Pouch Inlet in Patients With Inflammatory Bowel Disease", "year": "2019"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:_FM0Bhl9EiAC", "citedby": "0"}, {"bib": {"title": "Outcome of elective switching to vedolizumab in inflammatory bowel disease patients under tumor necrosis factor antagonist\u2010maintained clinical remission", "year": "2019"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:Z5m8FVwuT1cC", "citedby": "0"}, {"bib": {"title": "FUT2 Genotype Is Not Associated With Disease Phenotype or Outcomes in Patients With Crohn's Disease: 696", "year": "2019"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:XoXfffV-tXoC", "citedby": "0"}, {"bib": {"title": "Low Skeletal Muscle Index Is an Independent Risk Factor for Inflammatory Bowel Disease Surgical Complications: 765", "year": "2019"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:ruyezt5ZtCIC", "citedby": "0"}, {"bib": {"title": "Sa1277 POEM AS SALVAGE THERAPY FOR ACHALASIA AFTER FAILED ENDOSCOPIC OR SURGICAL THERAPY IS TECHNICALLY FEASIBLE AND SAFE-A SYSTEMATIC REVIEW AND META-ANALYSIS", "year": "2019"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:BUYA1_V_uYcC", "citedby": "0"}, {"bib": {"title": "572\u2013Prophylactic Antibiotic Therapy for Spontaneous Bacterial Peritonitis: A Systemic Review and Network Meta-Analysis", "year": "2019"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:URolC5Kub84C", "citedby": "0"}, {"bib": {"title": "Sa1845\u2013Follow-Up of Ulcerative Colitis Patients with Normalized Histology", "year": "2019"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:vDijr-p_gm4C", "citedby": "0"}, {"bib": {"title": "Su1925\u2013Non-Adherence to Maintenance Medications is Common in Pregnant Ulcerative Colitis Patients and Contribute to Disease Flares and Adverse Pregnancy Outcomes-A Multicenter \u2026", "year": "2019"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:epqYDVWIO7EC", "citedby": "0"}, {"bib": {"title": "1088\u2013Meta-Analysis: the Risk of Developing New Onset Inflammatory Bowel Disease with Interleukin-17 Blockade Therapy", "year": "2019"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:zLWjf1WUPmwC", "citedby": "0"}, {"bib": {"title": "Increased Risk of Endoscopic Disease Progression With Rutgeerts' i2a and i2b Recurrence: Implications for Disease Prevention: 694", "year": "2018"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:S16KYo8Pm5AC", "citedby": "0"}, {"bib": {"title": "Treatment With Cyclosporine After Infliximab Failure in Hospitalized Patients With Acute Severe Ulcerative Colitis Is Effective and Safe: 693", "year": "2018"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:e_rmSamDkqQC", "citedby": "0"}, {"bib": {"title": "Increased Risk of Endoscopic Disease Progression With Rutgeerts' i2a and i2b Recurrence: Implications for Disease Prevention", "year": "2018"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:9Nmd_mFXekcC", "citedby": "0"}, {"bib": {"title": "Treatment With Cyclosporine After Infliximab Failure in Hospitalized Patients With Acute Severe Ulcerative Colitis Is Effective and Safe", "year": "2018"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:XD-gHx7UXLsC", "citedby": "0"}, {"bib": {"title": "Correction to: Risk Factors for Clostridium difficile Isolation in Inflammatory Bowel Disease: A Prospective Study", "year": "2018"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:fEOibwPWpKIC", "citedby": "0"}, {"bib": {"title": "Gastrointestinal cancer risk in cystic fibrosis: more exploration is needed\u2013Authors' reply", "year": "2018"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:1yQoGdGgb4wC", "citedby": "0"}, {"bib": {"title": "ENDOSCOPIC ULTRASOUND GUIDED FIDUCIAL PLACEMENT IN GASTROINTESTINAL MALIGNANCIES. A SYSTEMATIC REVIEW AND METANALYSIS", "year": "2018"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:OR75R8vi5nAC", "citedby": "0"}, {"bib": {"title": "Su1884-Combination Therapy with Anti-TNF and Immunosuppressive Therapies is the Most Effective Medications to Prevent and Treat Endoscopic Postoperative Recurrence in Patients \u2026", "year": "2018"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:eq2jaN3J8jMC", "citedby": "0"}, {"bib": {"title": "94-Daily Aspirin Use does not Impact Clinical Outcomes in Patients with Inflammatory Bowel Disease", "year": "2018"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:SdhP9T11ey4C", "citedby": "0"}, {"bib": {"title": "Sa1741-Rates of Ustekinumab Deep Remission: A Real-World Tertiary Care Center Experience", "year": "2018"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:9vf0nzSNQJEC", "citedby": "0"}, {"bib": {"title": "Tu1700-Ethnic Variation of Thiopurine Methyltransferase Enzyme Activity and Risk of Adverse Event in Patients with Inflammatory Bowel Disease", "year": "2018"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:dTyEYWd-f8wC", "citedby": "0"}, {"bib": {"title": "Mo1911-Higher Vitamin D Levels Correlate with Reduced Risk of Post-Operative Recurrence in Crohn's Disease", "year": "2018"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:JoZmwDi-zQgC", "citedby": "0"}, {"bib": {"title": "601-Natural History of Crohn's Disease Postoperative Recurrence in a US Referral Center in the Era of Biologics and Therapeutic Intensification Based on Early Endoscopic Findings", "year": "2018"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:PELIpwtuRlgC", "citedby": "0"}, {"bib": {"title": "P185 Natural history of Crohn\u2019s disease postoperative recurrence in a referral centre in the era of biologics and therapeutic intensification based on early endoscopic findings", "year": "2018"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:XiVPGOgt02cC", "citedby": "0"}, {"bib": {"title": "P373 Daily aspirin use does not impact clinical outcomes in patients with inflammatory bowel disease", "year": "2018"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:5ugPr518TE4C", "citedby": "0"}, {"bib": {"title": "immunogenicity of infliximab originator vs. CT\u2010P13 in IBD patients\u2014authors\u2019 reply", "year": "2017"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:V3AGJWp-ZtQC", "citedby": "0"}, {"bib": {"title": "CT\u2010P13, a biosimilar of anti\u2010tumour necrosis factor\u2010alpha agent (infliximab), in inflammatory bowel diseases\u2013authors\u2019 reply", "year": "2017"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:8AbLer7MMksC", "citedby": "0"}, {"bib": {"title": "Risk of Postoperative Complications Among Inflammatory Bowel Disease Patients Treated Preoperatively with Anti-integrin and Anti-Tumor Necrosis Factor Agents", "year": "2017"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:fQNAKQ3IYiAC", "citedby": "0"}, {"bib": {"title": "The Benefit of Combination Therapy Depends on Disease Phenotype and Duration in Crohn's Disease: A Prospective Cohort Study", "year": "2017"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:LPZeul_q3PIC", "citedby": "0"}, {"bib": {"title": "Efficacy of Calcineurin Inhibitors During Induction and Maintenance of Remission with Vedolizumab in IBD", "year": "2017"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:5Ul4iDaHHb8C", "citedby": "0"}, {"bib": {"title": "Comparison of real-world outcomes of adalimumab and infliximab for patients with ulcerative colitis in the United States", "year": "2017"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:1qzjygNMrQYC", "citedby": "0"}, {"bib": {"title": "P676 Comparison of real-world outcomes of adalimumab and infliximab for patients with ulcerative colitis in the United States", "year": "2017"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:vRqMK49ujn8C", "citedby": "0"}, {"bib": {"title": "Risk of Cancer Recurrence Among Individuals Exposed to Antitumor Necrosis Factor Therapy", "year": "2017"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:0KyAp5RtaNEC", "citedby": "0"}, {"bib": {"title": "Crohn's Disease, Antibiotic Use, and Recent Health Care Exposures Are Associated withClostridium difficileIsolation in IBD: 590", "year": "2016"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:geHnlv5EZngC", "citedby": "0"}, {"bib": {"title": "Predictive Probability Score for 30-Day Readmissions in Inflammatory Bowel Disease: 596", "year": "2016"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:sSrBHYA8nusC", "citedby": "0"}, {"bib": {"title": "Failure to Account for Immortal Person Time Likely Accounts for the Apparent Reduction in Surgery Among Natalizumab Users", "year": "2016"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:ZuybSZzF8UAC", "citedby": "0"}, {"bib": {"title": "Mo1293 Characterization of Disease Related Factors in Microscopic Colitis", "year": "2016"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:nb7KW1ujOQ8C", "citedby": "0"}, {"bib": {"title": "Tu1906 Risk of Cancer Recurrence Among Individuals Exposed to Anti-Tumor Necrosis Factor Therapy: A Meta-Analysis of Observational Studies", "year": "2016"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:P5F9QuxV20EC", "citedby": "0"}, {"bib": {"title": "Tu1917 Risk of Pregnancy Related Complications With Anti-TNFalpha Therapy in Immune Mediated Diseases; A Systematic Review and Meta-Analysis", "year": "2016"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:CHSYGLWDkRkC", "citedby": "0"}, {"bib": {"title": "The \u201cMoonsault\u201d maneuver: retroflexed ileocecal valve insertion", "year": "2016"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:SeFeTyx0c_EC", "citedby": "0"}, {"bib": {"title": "Feasibility and Diagnostic Yield of Trans-Nasal Esophagogastroduodenoscopy (TN-EGD) Compared to Conventional EGD (C-EGD) for Screening of Upper Gastrointestinal Disease: A \u2026", "year": "2015"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:kzcrU_BdoSEC", "citedby": "0"}, {"bib": {"title": "Two Cases of Hermansky-Pudlak Syndrome Highlight a Potential Biologic Explanation for Associated Crohn's Disease: 688", "year": "2015"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:Fu2w8maKXqMC", "citedby": "0"}, {"bib": {"title": "Efficacy and Safety of Tacrolimus Therapy for Severe and Steroid-refractory Ulcerative Colitis: A Systematic Review and Meta-analysis: 1958", "year": "2015"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:W5xh706n7nkC", "citedby": "0"}, {"bib": {"title": "Comparison of Real World Outcomes of Adalimumab and Infliximab for Patients With Moderate or Severe Ulcerative Colitis in the United States: 1815", "year": "2015"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:uLbwQdceFCQC", "citedby": "0"}, {"bib": {"title": "Mo2006 Risk of Gastrointestinal Cancers in Cystic Fibrosis: A Systematic Review and Meta-Analysis", "year": "2015"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:NMxIlDl6LWMC", "citedby": "0"}, {"bib": {"title": "Mo1757 Evidence for a Role of Superantigens in the Pathogenesis of Ulcerative Colitis-Associated Primary Sclerosing Cholangitis", "year": "2015"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:hMod-77fHWUC", "citedby": "0"}, {"bib": {"title": "The Risk of Formation of Neutralizing Antibodies", "year": "2015"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:ldfaerwXgEUC", "citedby": "0"}, {"bib": {"title": "What Is the Best Possible Therapy for My Crohn\u2019s Disease? State-of-the-Art Therapy for Newly Diagnosed Crohn\u2019s Disease", "year": "2015"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:JV2RwH3_ST0C", "citedby": "0"}, {"bib": {"title": "Apheresis Therapy for IBD", "year": "2014"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:9ZlFYXVOiuMC", "citedby": "0"}, {"bib": {"title": "555 Correlation Between Serum Vitamin D With Tissue VDR, Colonic Epithelial Junction Transcripts, and Mucosal Inflammation in a Prospective Ulcerative Colitis Cohort", "year": "2014"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:isC4tDSrTZIC", "citedby": "0"}, {"bib": {"title": "Mo1183 Prevalence of Serum JC Virus Antibody in Refractory Crohn's Disease Patients", "year": "2014"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:e5wmG9Sq2KIC", "citedby": "0"}, {"bib": {"title": "Oral Mesalamine", "year": "2014"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:iH-uZ7U-co4C", "citedby": "0"}, {"bib": {"title": "Su1206 Mucosal Healing Is Associated With Improved Long-Term Outcome of Maintenance Therapy With Natalizumab in Crohn's Disease", "year": "2013"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:qUcmZB5y_30C", "citedby": "0"}, {"bib": {"title": "Natalizumab in Crohn's Disease: Results from a US Tertiary IBD Center: 1663", "year": "2012"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:uJ-U7cs_P_0C", "citedby": "0"}, {"bib": {"title": "Meta-Analysis of the Efficacy and Safety of Bisphosphonate Therapy in Inflammatory Bowel Disease: 1661", "year": "2012"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:j3f4tGmQtD8C", "citedby": "0"}, {"bib": {"title": "Biologic Therapy of Crohn\u2019s Disease: Infliximab", "year": "2012"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:IWHjjKOFINEC", "citedby": "0"}, {"bib": {"title": "Digestive Disease Week 2011: An Update on IBD Basic Science", "year": "2011"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:ns9cj8rnVeAC", "citedby": "0"}, {"bib": {"title": "GASTROINTESTINAL SYPHILIS WITH TREPONEMA PALLIDUM NOTED ON IMMUNOHISTOCHEMISTRY OF GASTRIC AND ILEAL MUCOSA SPECIMENS", "year": "2008"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:SP6oXDckpogC", "citedby": "0"}, {"bib": {"title": "A multicenter randomized controlled trial between weekly and semiweekly granulocyte and mono-cyte apheresis for active ulcerative colitis: IS-1\u20134", "year": "2007"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:Tiz5es2fbqcC", "citedby": "0"}, {"bib": {"title": "Granulocyte and monocyte adsorption apheresis therapy modulates monocyte derived dentritic cell function in patients with ulcerative colitis: IW-8\u20134", "year": "2007"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:u9iWguZQMMsC", "citedby": "0"}, {"bib": {"title": "Profiling of amino acids metabolism (\" Amino index\") is useful for diagnosis, judgment of clinical activity, and understanding of pathophysiology in inflammatory bowel disease", "year": "2007"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:4JMBOYKVnBMC", "citedby": "0"}, {"bib": {"title": "Novel endoscopic activity index is useful to decide treatment options of active ulcerative colitis", "year": "2007"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:_Qo2XoVZTnwC", "citedby": "0"}, {"bib": {"title": "Capsule Endoscopy Is Useful in Assessing Intestinal Lesions of Behcet's Disease: 1390", "year": "2006"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:L8Ckcad2t8MC", "citedby": "0"}, {"bib": {"title": "The constitution and distribution of intestinal bacterial flora in patients with inflammatory bowel disease: Genus or species specific analysis based on 16s rRNA gene sequences \u2026", "year": "2006"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:TFP_iSt0sucC", "citedby": "0"}, {"bib": {"title": "Dysregulated Immune Response in Mesenteric Lymph Nodes of Crohn's Disease: 873", "year": "2005"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:k_IJM867U9cC", "citedby": "0"}, {"bib": {"title": "\u708e\u75c7\u6027\u8178\u75be\u60a3\u306e\u6700\u8fd1\u306e\u77e5\u898b (\u7279\u96c6 \u708e\u75c7\u6027\u8178\u75be\u60a3--\u6cbb\u7642\u306b\u304a\u3051\u308b\u6700\u8fd1\u306e\u9032\u6b69)", "year": "2005"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:QIV2ME_5wuYC", "citedby": "0"}, {"bib": {"title": "Current Issues in Steroid-resistant and Dependant Ulcerative Colitis", "year": "2005"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:r0BpntZqJG4C", "citedby": "0"}, {"bib": {"title": "Osteopontin/Eta-1 upregulated in Crohn's disease regulates the Th1 immune response. Commentary", "year": "2005"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:HDshCWvjkbEC", "citedby": "0"}, {"bib": {"title": "Interaction between dendritic cells and T cells in the mesenteric lymph nodes of inflammatory bowel disease", "year": "2004"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:mB3voiENLucC", "citedby": "0"}, {"bib": {"title": "Irritable bowel syndrome-T-bet upregulation and subsequent interleukin 12 stimulation are essential for induction of Th1 mediated immunopathology in Crohn's disease", "year": "2004"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:-f6ydRqryjwC", "citedby": "0"}, {"bib": {"title": "Platelet activation and interaction with leukocytes in patients with ulcerative colitis: a novel marker for prediction of efficacy of granulocyte and monocyte adsorption apheresis", "year": "2003"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:R3hNpaxXUhUC", "citedby": "0"}, {"bib": {"title": "Phenotypic and functional analysis of dendritic cells isolated from the mesenteric lymph nodes of human inflammatory bowel disease", "year": "2003"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:Wp0gIr-vW9MC", "citedby": "0"}, {"bib": {"title": "Up-regulation of osteopontin and its pathogenetic role in Crohn's disease", "year": "2002"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:TQgYirikUcIC", "citedby": "0"}, {"bib": {"title": "Effect of atorvastatin on colonic epithelial cells and its application to therapy for ulcerative colitis", "year": "2002"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:hC7cP41nSMkC", "citedby": "0"}, {"bib": {"title": "T-bet is indispensable for intestinal inflammation of Crohn's disease", "year": "2002"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:7PzlFSSx8tAC", "citedby": "0"}, {"bib": {"title": "Endoscopic Characteristics and Prognosis of Pouchitis Involving the Pouch Inlet in Patients with Inflammatory Bowel Disease Treated by Proctocolectomy with Ileal Pouch-Anal \u2026"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:NXb4pA-qfm4C", "citedby": "0"}, {"bib": {"title": "Our thanks to those who have helped with this issue of Expert Review of Gastroenterology & Hepatology. Listed below are the authors, referees and others who have kindly given \u2026"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:L7CI7m0gUJcC", "citedby": "0"}, {"bib": {"title": "MINI-REVIEW ARTICLE"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:UxriW0iASnsC", "citedby": "0"}, {"bib": {"title": "Our thanks to those who have helped with this issue of Expert Review of Gastroenterology and Hepatology. Listed below are the authors, referees and others who have kindly given \u2026"}, "source": "citations", "id_citations": "M3rqwfgAAAAJ:qxL8FJ1GzNcC", "citedby": "0"}]}